CONTROL◐ DEVELOPINGI · Intelligence◆ Concentrating
OpenAI funds biology data creation via failed-biotech records strategy
Sep 15, 2026SOURCE: technologyreview.com
SO WHAT
In the thousand-day window, richer biomedical inputs can accelerate the inversion of human clinical know-how into models—if access stays controlled by a few owners.
A policy proposal would mine detailed regulatory and manufacturing material from bankrupt firms. OpenAI is reported to be paying to generate more biology-relevant data for medical AI.
This is Negative Resistance’s reframed reading of a reported signal. The headline and analysis above are our interpretation through the thousand-day-window lens. The original reporting lives at the source linked above.